Journal of Cardiology Research Review & Reports最新文献_第2页

A Case of Complete Heart Block Presenting as Resistant Hypertensive Emergency 完全性心脏传导阻滞为难治性高血压急症1例

Journal of Cardiology Research Review & Reports Pub Date : 2022-04-30 DOI: 10.47363/jcrrr/2022(3)159

Larissa Check

引用次数: 0

Enhanced Cardiovascular Risk Assessment in United States Subjects for Deployment to Antarctica 部署到南极洲的美国受试者加强心血管风险评估

Journal of Cardiology Research Review & Reports Pub Date : 2022-04-30 DOI: 10.47363/jcrrr/2022(3)158

Masood Ahmad, Patricia Rodriguez-Lozano

{"title":"Enhanced Cardiovascular Risk Assessment in United States Subjects for Deployment to Antarctica","authors":"Masood Ahmad, Patricia Rodriguez-Lozano","doi":"10.47363/jcrrr/2022(3)158","DOIUrl":"https://doi.org/10.47363/jcrrr/2022(3)158","url":null,"abstract":"Introduction: Coronary artery disease (CAD) is the leading cause of death in developed nations. Nearly half of asymptomatic CAD cases initially present as acute myocardial infarction (MI) or sudden cardiac death.Therefore, assessment of cardiovascular health is important in subjects who are deployed to remote stations with limited access to medical care, such as Antarctica. Effective screening strategies for detecting CAD and minimizing the risk of acute cardiovascular events in the deployed subjects are essential to mission success. Our study for the first time describes cardiovascular risk assessment in US subjects prior to their deployment to Antarctica. Methods: This report is a single center retrospective analysis of 135 subjects who underwent advanced cardiovascular screening from October 2013 to November 2017 prior to their deployment to Antarctica. Of the 135 subjects, 128 were assessed to be acceptable cardiac risk and were approved for deployment. However, only a total of 100 subjects proceeded for deployment to the South Pole. The deployment periods ranged from 6 to 324 days with a mean of 94.4 days (SD 73.8). All deployed subjects were exposed to the harsh cold climate in Antarctica. Primary outcomes include cardiovascular events such as acute myocardial infarction, unstable angina pectoris, congestive heart failure, cardiac arrhythmias, and sudden cardiac death. Results: None of the 100 subjects had cardiac events reported during their deployment. Conclusions: The current enhanced cardiovascular screening process, prior to deployment to US Antarctic Program stations, appears effective in identifying subjects with low risk of cardiac events.","PeriodicalId":430938,"journal":{"name":"Journal of Cardiology Research Review & Reports","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121076121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Post-Stroke Fatigue: Difficulties in Measurement and Treatment 脑卒中后疲劳:测量和治疗的困难

Journal of Cardiology Research Review & Reports Pub Date : 2021-04-30 DOI: 10.47363/jcrrr/2021(2)141

Ank A Agarwal

{"title":"Post-Stroke Fatigue: Difficulties in Measurement and Treatment","authors":"Ank A Agarwal","doi":"10.47363/jcrrr/2021(2)141","DOIUrl":"https://doi.org/10.47363/jcrrr/2021(2)141","url":null,"abstract":"Post-stroke fatigue (PSF) affects millions of patients worldwide. It is categorized by debilitating fatigue and lack of motivation pervading numerous aspects of daily life. These difficulties affect patients physically, mentally, socially, and emotionally. Current measurements show that anywhere from 25% to 75% of the 17 million people globally who suffer a first-time stroke every year may also suffer from post-stroke fatigue. However, measuring post-stroke fatigue is fraught with numerous issues. Researchers differ in their specific definitions of the condition, and there are various scales used to measure the severity of this fatigue. Moreover, many studies exclude patients in measurement if they have comorbidities such as depression, resulting in an added measure of complexity for comparing and creating meaningful conclusions. Post-stroke fatigue also has limited treatment options, many of which are limited in efficacy at best. Current efforts aim to treat the condition from a variety of lenses, including pharmacological, physical, psychological, and environmental. However, the best interventions are yet to be developed and will likely arise from improved understanding of post-stroke fatigue etiology and associated factors. Herein, we present a brief review of the difficulties in measuring stroke prevalence and treating the condition.","PeriodicalId":430938,"journal":{"name":"Journal of Cardiology Research Review & Reports","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129940244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Human Leukocyte Antigen Mismatch is Associated with Grade 3 Primary Graft Dysfunction at 72 Hours Following Bilateral Sequential Lung Transplantation: A Single-Center, Retrospective Cohort Study 人类白细胞抗原错配与双侧序贯肺移植术后72小时3级原发性移植物功能障碍相关:一项单中心、回顾性队列研究

Journal of Cardiology Research Review & Reports Pub Date : 2021-04-30 DOI: 10.47363/jcrrr/2021(2)140

Tjörvi E Perry

{"title":"Human Leukocyte Antigen Mismatch is Associated with Grade 3 Primary Graft Dysfunction at 72 Hours Following Bilateral Sequential Lung Transplantation: A Single-Center, Retrospective Cohort Study","authors":"Tjörvi E Perry","doi":"10.47363/jcrrr/2021(2)140","DOIUrl":"https://doi.org/10.47363/jcrrr/2021(2)140","url":null,"abstract":"Background: The role of donor-recipient human leukocyte antigen (HLA) mismatch as a risk factor for developing primary graft dysfunction (PGD) after lung transplantation is not well understood. We describe a novel association between increased donor-recipient HLA mismatch and grade 3 PGD after bilateral lung transplantation. Methods: We retrospectively evaluated donor and recipient demographic data, co-morbidities, intraoperative interventions and outcomes in 99 consecutive adult patients undergoing primary bilateral lung transplantation. The primary outcome of this study was grade 3 PGD at 72 hours. Secondary outcomes included intensive care and hospital lengths of stay and mortality. Results: Eighteen patients (18%) met criteria for grade 3 PGD at 72 hours postoperatively. More non-Caucasian recipients (27.8% vs. 7.4%, p=0.026), and more patients with interstitial lung disease (72.2% vs 43.2%, p=0.031) developed grade 3 PGD. The use of inhaled epoprostenol (OR 4.38, 95% CI: 1.02-20.16, p=0.048), increased HLA mismatches (OR 2.85, 95% CI: 1.31-7.45, p=0.017) and the use of each 250mL unit of PRBCs during the intraoperative period (OR 0.77, 95% CI: 0.58-0.97, p=0.048) were independently associated with grade 3 PGD. Patients diagnosed with grade 3 PGD spent significantly longer time in the intensive care unit (22 days [6;74 days] vs. 7 days [2;83 days], p=<0.001) and hospital (30.5 days [10;83 days] vs. 18 days [3;97 days], p=0.012), and survival was significantly worse for those with PGD3 at 72 hours (log-rank p=0.009). Conclusion: Our data indicate, for the first time, that HLA donor-recipient mismatch is an independent risk factor for developing grade 3 PGD at 72 hours after bilateral lung transplantation.","PeriodicalId":430938,"journal":{"name":"Journal of Cardiology Research Review & Reports","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114548736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

An Assessment of Clinician and Patient Baseline Knowledge and Preferences Regarding Red Blood Cell Transfusions in Cardiac and Non-Cardiac Surgery 对心脏和非心脏手术中红细胞输注的临床医生和患者基线知识和偏好的评估

Journal of Cardiology Research Review & Reports Pub Date : 2021-04-30 DOI: 10.47363/jcrrr/2021(2)139

Tjörvi E Perry

{"title":"An Assessment of Clinician and Patient Baseline Knowledge and Preferences Regarding Red Blood Cell Transfusions in Cardiac and Non-Cardiac Surgery","authors":"Tjörvi E Perry","doi":"10.47363/jcrrr/2021(2)139","DOIUrl":"https://doi.org/10.47363/jcrrr/2021(2)139","url":null,"abstract":"Purpose: To delineate the current knowledge of, and preference for perioperative red blood cell transfusion by clinician and patients. Methods: In this single center study, clinicians and patients were asked to complete a 21-item survey, and a 19-item survey, respectively. Results: On a 7-point category scale, clinicians felt more knowledgeable about when red blood cells should be transfused (5.5 vs 2.1; p<0.0001), clinicians, in preparation for open heart surgery, were more interested in hearing about the risks and benefits of a blood transfusion (4.6 vs 2.6; p<0.0001), and more clinicians felt it was important for them to be involved in deciding whether they should receive a blood transfusion (5.7 vs 5.0; p=0.015). The majority of clinicians chose hemoglobin triggers of either <7.5 mg/dL for non-cardiac surgery or 7.5-8.9 mg/dL for cardiac surgery, while patients either felt they did not have enough information or did not know. Conclusion: Our results highlight important differences between clinicians and patients in the basic knowledge about, and preferences for perioperative red blood transfusion, and imply a clinician-driven decision model to transfuse RBCs, and supports future efforts to develop decision aids to facilitate patient involvement in the shared decision-making about perioperative transfusion.","PeriodicalId":430938,"journal":{"name":"Journal of Cardiology Research Review & Reports","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122898525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Risk Probability of Having a Cardiovascular Disease, Stroke, or Renal Complications Using Annual Segmented Data of Glucose and Metabolism Index (GH Method: Math-Physical Medicine) 利用年度葡萄糖和代谢指数分段数据分析患心血管疾病、中风或肾脏并发症的风险概率(GH方法:数学-物理医学)

Journal of Cardiology Research Review & Reports Pub Date : 2020-06-30 DOI: 10.47363/jcrrr/2020(1)116

Gerald C. Hsu

引用次数: 0

Drug Repositioning For The Prophylaxis And Treatment Of Covid-19 预防和治疗Covid-19的药物重新定位

Journal of Cardiology Research Review & Reports Pub Date : 2020-06-30 DOI: 10.47363/jcrrr/2020(1)108

M. Al-Noaemi

{"title":"Drug Repositioning For The Prophylaxis And Treatment Of Covid-19","authors":"M. Al-Noaemi","doi":"10.47363/jcrrr/2020(1)108","DOIUrl":"https://doi.org/10.47363/jcrrr/2020(1)108","url":null,"abstract":"Coronaviruses are large, enveloped, single-stranded, positive-sense RNA viruses and belong to the family coronaviridae. Other viruses from the same family include the severe acute respiratory syndrome coronavirus (SARS-CoV), which appeared in 2002 in China, and Middle East respiratory syndrome coronavirus (MERS-CoV ), which appeared in 2012 in Saudi Arabia. In december 2019, several patients from Wuhan, China were admitted with symptoms of pneumonia. A new virus was identified and initially called the 2019 novel coronavirus (2019-nCoV). On january 30, 2020, the World Health Organization (WHO) named the disease as “COVID-19” which is coronavirus disease 2019. On March 11, 2020, the WHO described its outbreak as a pandemic. Chloroquine (CQ), the antimalarial drug, elicit antiviral effects against several viruses. Previous studies reported the antiviral activity of CQ against many human coronaviruses (HCoVs) such as SARS-CoV, MERS-CoV, and HCoV-OC43. Recent in vitro studies (2020) reported that CQ and hydroxychloroquine (HCQ) is effective in inhibiting SARS-CoV-2 infection. In China, in February 2020 over 100 patients treated with (CQ) resulted in significant improvement of pneumonia. In France, on March 17, 2020, some of the COVID-19 patients were treated with (HCQ) and others treated with HCQ in combination with azithromycin to prevent bacterial infection.","PeriodicalId":430938,"journal":{"name":"Journal of Cardiology Research Review & Reports","volume":"233 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131166425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

How to Reverse Chronic Disease Induced Heart Conditions Using a Simple and Effective “Cookbook of Quantitative Formulas” (GHMethod: Math-Physical Medicine) 如何用简单有效的“定量配方食谱”逆转慢性病诱发的心脏病(GHMethod:数理医学)

Journal of Cardiology Research Review & Reports Pub Date : 2020-06-30 DOI: 10.47363/jcrrr/2020(1)110

Gerald C. Hsu

引用次数: 1

Using GH-Method: Math-Physical Medicine to Investigate the Risk Probability of Metabolic Disorders Induced Cardiovascular Diseases, Stroke, and Renal Complications 利用GH-Method:数学-物理医学研究代谢性疾病诱发心血管疾病、中风和肾脏并发症的风险概率

Journal of Cardiology Research Review & Reports Pub Date : 2020-06-30 DOI: 10.47363/jcrrr/2020(1)111

Gerald C. Hsu

引用次数: 1

Glycated Haemoglobin as Seen at the Plateau Specialist Hospital, Jos. Nigeria 乔斯高原专科医院的糖化血红蛋白尼日利亚

Journal of Cardiology Research Review & Reports Pub Date : 2020-06-30 DOI: 10.47363/jcrrr/2020(1)115

Chundusu Caleb

{"title":"Glycated Haemoglobin as Seen at the Plateau Specialist Hospital, Jos. Nigeria","authors":"Chundusu Caleb","doi":"10.47363/jcrrr/2020(1)115","DOIUrl":"https://doi.org/10.47363/jcrrr/2020(1)115","url":null,"abstract":"The use of glycated haemoglobin (Hba1C) in assessing long term glycemic control is well known. However, its use as cardiovascular risk remains controversial. Availability, technicality and cost has made it uncommon among the developing countries. A short over view may add up to the scanty literature on HBA1c in Plateau Specialist Hospital, Jos. Nigeria. Design and methods: We conducted a retrospective analysis of HBA1c records from the side-laboratory of the Jos University Teaching Hospital. The test was determined using STANDARD TM A1cCare analyzer. Results: A total of 264 patients were tested in the “point-of-care” laboratory within six months (1st quarter 2020). They consisting of 149 (56.4%) female, with a total mean age of 55years. 80.7% of total records were diabetic and 14.4% diabetic hypertensive. A heterogeneous group of non-diabetics consist of the remaining 19.3%. The non-diabetic group had a mean HBA1c of 6.79 % (+/- 2.2). The group of diabetes without hypertension had a mean HBA1c 8.54% (+/- 2.9) while diabetic hypertensive had a mean HBA1c of 8.8% (+/- 3.7). AVOVA showed significant variation in the three group (p<0.002). a two-unpaired t-test among the two diabetic group showed no statistical difference (p-0.66). Conclusion: Patients that are not diagnosed to be diabetic attending clinics for other aliments were more likely to be pre-diabetics. Long term diabetic control in the Jos University Teaching Hospital is rather poor and hypertension appear not to have significant effect on HBA1c level.","PeriodicalId":430938,"journal":{"name":"Journal of Cardiology Research Review & Reports","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122767147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Journal of Cardiology Research Review &amp; Reports最新文献

Journal of Cardiology Research Review & Reports最新文献